Purchase Order N6311621P0539
Award Date
6/8/21
Potential Completion Date
12/6/21
Potential Value
$99K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a firm fixed price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $102,361.40 contract is for the provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract is not set aside for any...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
This is a $41,137.76 firm fixed price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract is for the delivery of Illumina RNA Prep kits and reagents to support laboratories at the Naval Health Research Center (NHRC) in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), with deliveries scheduled on four dates between...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $88,773.98 award is for Illumina reagent kits to support NIAID's COVID-19 research and response efforts. Illumina has previously provided a range of genomic sequencing instruments, consumables, and services to federal agencies including the NIH, CDC, USDA, and VA....
This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...